ESTRO37_ProgrammeBook

> Radical approach to primary unresectable rectal cancer–what is the optimal road? M. Kraszkiewicz (Poland), J. Wydmanski, W. Majewski > Palliative RT: new score to estimate survival times of patients with gastrointestinal malignancies C. Kerger, C. Straube (Germany), A. Hapfelmeier, S.E. Combs, D. Habermehl > Cetuximab,Capecitabine,3D-CRT vs capecitabine,3D-CRT as preoperative treatment in rectal cancer P. Mavroeidi (Greece) > Cetuximab,Capecitabine,3D-CRT vs capecitabine,3D-CRT as preoperative treatment in rectal cancer P. Mavroeidi (Greece), A. Varveris, A. Spanakis, C. Varveris > Endoscopic evaluation for radiation proctitis in patients receiving intermediate-dose radiotherapy J. Lee (Republic of Korea), H. Hee Ji, M. Byung So, H. Sung Pil, S. Sang Joon, Y. Hong in, P. Soo Jung, K. Woong Sub > Impact of pelvis irradiation on toxicity of further oxaliplatin-based chemotherapy in rectal cancer M. Spalek (Poland), W. Michalski, K. Bujko, L. Wyrwicz > Neoadjuvant VMAT radiochemotherapy with a SIB Compared to standard Chemoradiation for LARC N. Jankarashvili (Georgia), M. Topeshashvili, L. Turkiashvili, B. Metonidze, E. Dgebuadze, T. Melkadze, I. Kiladze, G. Korakhashvili > induction chemotherapy followed by chemoradiotherapy in locally advanced anal canal carcinoma I. Benevento (Italy), M. Venezia, L. Mistrulli, F. De Felice, D. Musio, R. Caiazzo, V. Tombolini > Microscopic extension of residual rectal tumor mass post-neoadjuvant chemoradiation: a meta-analysis A. Verrijssen (The Netherlands), M. Bellezzo, A. Habr-Gama, R. Perez, J. Guillem, K. Bujko, R. Houben, F. Verhaegen, M. Berbee, E. Van Limbergen > Prediction of pathologic staging with MRI after neoadjuvant chemoradiation for Rectal Cancer C. De la Pinta Alonso (Spain), M. Martín Martín, E. Fernández-Lizarbe, A. Hervás Morón, F. López-Campos, S. Sancho García

EP-1464

ELECTRONIC POSTERS

EP-1465

EP-1466

EP-1467

EP-1468

EP-1469

EP-1470

EP-1471

EP-1472

EP-1473

POSTERS AND ELECTRONIC POSTERS | Programme and Exhibition Guide

286